Treatment of Severe Atopic Dermatitis with Dupilumab in Three Patients with Renal Diseases
Background: Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease that can affect patients’ quality of life. Dupilumab is the first biologic agent approved for the treatment of patients with inadequately controlled moderate-to-severe AD and its mechanism of action is based on the i...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2022-11-01
|
| Collection: | Life |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2075-1729/12/12/2002 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|